Little Green Pharma (LGP) has been granted a new Manufacture Permit over its manufacturing facility by the Office of Drug Control (ODC).
LGP said the manufacture permit, which has been granted until 10 March 2021, will allow it to manufacture cannabis extracts for supply to holders of Therapeutic Goods Administration (TGA).
LGP Managing Director Fleta Solomon said the permit will enable LGP to commence in-house extraction once the next crop is harvested, resulting in reduced manufacturing costs and improved manufacturing efficiencies.
“Receiving this Manufacture Permit gives us the internal capability to manufacture cannabis extracts at our manufacturing premises and is a significant event for Little Green Pharma,” Ms Solomon said.
“We are now only waiting for our expanded ODC Medicinal Cannabis Cultivation and Production Permit which, once granted, will allow us to begin first planting at our expanded cultivation facility and to significantly expand our production operations.
“This increased production capacity will give Little Green Pharma the ability to meet both Australian and offshore demand for medicinal cannabis products. I look forward to updating the market once our expanded ODC Medicinal Cannabis Cultivation and Production Permit is granted.”
